Autosomal dominant hereditary axonal motor and sensory neuropathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:140456
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Autosomal dominant hereditary axonal motor and sensory neuropathy is a subtype of Charcot-Marie-Tooth disease type 2 (CMT2), a group of inherited peripheral neuropathies characterized by progressive degeneration of peripheral nerve axons rather than the myelin sheath. This condition primarily affects the peripheral nervous system, leading to progressive weakness and atrophy of distal muscles, particularly in the feet, lower legs, and hands. Sensory loss in a stocking-glove distribution is also a hallmark feature, and patients may experience reduced or absent deep tendon reflexes, foot deformities (such as pes cavus and hammer toes), and difficulties with balance and gait. The disease follows an autosomal dominant inheritance pattern, meaning that a single copy of the pathogenic variant inherited from one affected parent is sufficient to cause the condition. Multiple genetic loci have been associated with autosomal dominant CMT2, including mutations in genes such as MFN2, MPZ, NEFL, HSPB1, and others. Nerve conduction studies typically show normal or near-normal conduction velocities (above 38 m/s in the motor nerves of the upper limbs), distinguishing axonal forms from demyelinating forms of CMT. Onset is variable but often occurs in childhood, adolescence, or early adulthood, with a slowly progressive course. There is currently no cure or disease-modifying therapy for autosomal dominant hereditary axonal motor and sensory neuropathy. Management is supportive and multidisciplinary, including physical therapy to maintain muscle strength and flexibility, occupational therapy, orthotic devices (such as ankle-foot orthoses) to improve mobility, and surgical intervention for severe skeletal deformities when necessary. Pain management may be required for patients who experience neuropathic pain. Genetic counseling is recommended for affected individuals and their families.

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Autosomal dominant hereditary axonal motor and sensory neuropathy.

View clinical trials →

No actively recruiting trials found for Autosomal dominant hereditary axonal motor and sensory neuropathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Autosomal dominant hereditary axonal motor and sensory neuropathy community →

No specialists are currently listed for Autosomal dominant hereditary axonal motor and sensory neuropathy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Autosomal dominant hereditary axonal motor and sensory neuropathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Autosomal dominant hereditary axonal motor and sensory neuropathyForum →

No community posts yet. Be the first to share your experience with Autosomal dominant hereditary axonal motor and sensory neuropathy.

Start the conversation →

Latest news about Autosomal dominant hereditary axonal motor and sensory neuropathy

No recent news articles for Autosomal dominant hereditary axonal motor and sensory neuropathy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Autosomal dominant hereditary axonal motor and sensory neuropathy

What is Autosomal dominant hereditary axonal motor and sensory neuropathy?

Autosomal dominant hereditary axonal motor and sensory neuropathy is a subtype of Charcot-Marie-Tooth disease type 2 (CMT2), a group of inherited peripheral neuropathies characterized by progressive degeneration of peripheral nerve axons rather than the myelin sheath. This condition primarily affects the peripheral nervous system, leading to progressive weakness and atrophy of distal muscles, particularly in the feet, lower legs, and hands. Sensory loss in a stocking-glove distribution is also a hallmark feature, and patients may experience reduced or absent deep tendon reflexes, foot deformit

How is Autosomal dominant hereditary axonal motor and sensory neuropathy inherited?

Autosomal dominant hereditary axonal motor and sensory neuropathy follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.